[RUNX1 gene mutations are associated with adverse prognosis of patients with acute myeloidleukemia].

Abstract

OBJECTIVE:

To explore the rate and distribution of Runt- related transcription factor 1 (RUNX1) gene mutations in patients with acute myeloid leukemia (AML) and the correlation of these mutations with the clinical characteristics and survival outcomes of the patients.

METHODS:

The genomic DNA extracted from the bone marrow of 158 patients with newly diagnosed AML for PCR amplification of RUNX1 gene and sequence analysis to identify the mutations. The mutations of ASXL1, DNMT3A, TET2, FLT3, CEBPA, NPM1, IDH2, NRAS and c-KIT genes were also examined to analyze their association with RUNX1 gene mutations.

RESULTS:

Among the 158 AML patients, 19 (12.0%) were found to have RUNX1 mutations in A166G (9 cases), A142T (6 cases) and A162L (4 cases). RUNX1 mutations were more frequent in elderly patients (P < 0.01) and in cases of AML subtypes M4 and M5, and were associated with more frequent CD36 and CD7 expression as compared with the wild type. RUNX1 mutations were more likely to occur in patients with normal karyotype or karyotypes associated with moderate prognostic risks, but the difference was not significant (P > 0.05). The patients with RUNX1 mutations had significantly lower complete remission (CR) rate and overall survival (OS) rate than those without the mutations (P < 0.05). RUNX1 mutations were not associated with gender, white blood cell count upon diagnosis, hemoglobin level, platelet count, bone marrow blast cell ratio or lactate dehydrogenase level (P > 0.05).

CONCLUSIONS:

RUNX1 gene mutations are associated with an adverse prognosis of patients with AML.

• Authors: Yanli Yang, Tiantian Li, Yinghua Geng, Jun Li
• Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University (Nan Fang Yi Ke Da Xue Xue Bao) Vol. 40 Issue 11 Pg. 1601-1606 (Nov 30 2020) ISSN: 1673-4254 [Print] China
• PMID: 33243739 (Publication Type: Journal Article)

Chemical References

• Core Binding Factor Alpha 2 Subunit
• NPM1 protein, human
• RUNX1 protein, human
• Nucleophosmin

Topics

• Core Binding Factor Alpha 2 Subunit (genetics)
• Humans
• Leukemia, Myeloid, Acute (genetics)
• Mutation
• Nucleophosmin
• Prognosis
• Remission Induction